Aaon stock hits 52-week low at 66.29 USD

AAON Inc's stock plummeted to a 52-week low of $66.29, slightly above its 52-week low of $66.39. Over the past week, the stock rebounded by 9.4%, but it remains significantly below its 52-week high of $150.46. Analytical models indicate AAON may be undervalued, presenting potential upside for patients. This decline marks a 32.18% drop over the past year, influenced by both market challenges and company-specific factors.

Despite this volatility, AAON has maintained dividends for 21 consecutive years, showcasing financial stability. The upcoming earnings report in 10 days could offer critical insights. Investors can delve deeper with AAON's Pro Research Report, which includes 11 ProTips and extensive analysis. In 2026, the company outperformed expectations, reporting adjusted earnings of $0.69 per share and revenue of $626.97 million, marking four consecutive quarters of record revenue.

However, AAON's stock dipped, likely due to concerns over lower gross margins and growth investments. KeyBanc maintained a Sector Weight rating after inspecting AAON's Memphis facility. CEO Matt Tobolski and CFO Andy Cheung met with analysts during this visit. This report, AI-assisted and reviewed, underscores AAON's financial growth and analysts' cautious outlook.